Regen BioPharma Inc Cash And Cash Equivalents At Carrying Value

• Regen BioPharma Inc showed an increase of +9,614.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Regen BioPharma Inc's annual report (Form 10-K), filed with the SEC on December 30, 2025.
• XBRL data for this metric is available from 2012 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 12 years of available data (2012 to 2025), Regen BioPharma Inc's Cash And Cash Equivalents At Carrying Value has grown by 7,435.8%.
• Historical annual values: Fiscal year 2025: $69.6 thousand | Fiscal year 2024: $716.00 | Fiscal year 2023: $121.0 thousand | Fiscal year 2022: $51.2 thousand | Fiscal year 2021: $727.2 thousand | Fiscal year 2020: $0.00 | Fiscal year 2019: $7.9 thousand | Fiscal year 2018: $8.0 thousand | Fiscal year 2017: $270.0 thousand | Fiscal year 2016: $24.8 thousand | Fiscal year 2013: $115.9 thousand | Fiscal year 2012: $923.00.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026